NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Go back to NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
(NASDAQ: NRXP) Delayed: 3.32 -0.07 (2.06%)
Previous Close $3.39    52 Week High
Open $3.38    52 Week Low
Day High $3.42    P/E N/A 
Day Low $3.31    EPS
Volume 946,350       

(NASDAQ: NRXP) Delayed: 3.32 -0.07 (2.06%)
Previous Close $3.39    52 Week High
Open $3.38    52 Week Low
Day High $3.42    P/E N/A 
Day Low $3.31    EPS
Volume 946,350